BioSpecifics Technologies Corp.
BSTC
BSTC was delisted on the 1st of December, 2020.
90 hedge funds and large institutions have $199M invested in BioSpecifics Technologies Corp. in 2017 Q2 according to their latest regulatory filings, with 7 funds opening new positions, 34 increasing their positions, 34 reducing their positions, and 6 closing their positions.
17% more first-time investments, than exits
New positions opened: 7 | Existing positions closed: 6
1% more funds holding
Funds holding: 89 → 90 (+1)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
0% more repeat investments, than reductions
Existing positions increased: 34 | Existing positions reduced: 34
22% less capital invested
Capital invested by funds: $255M → $199M (-$56.2M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SCM
Stonepine Capital Management
Bend,
Oregon
|
+$3.14M |
| 2 |
Goldman Sachs
New York
|
+$2.87M |
| 3 |
Renaissance Technologies
New York
|
+$2.42M |
| 4 |
RHJA
Rice Hall James & Associates
San Diego,
California
|
+$1.63M |
| 5 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
+$1.48M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
NI
Numeric Investors
Boston,
Massachusetts
|
-$2.74M |
| 2 |
WCM
Wedge Capital Management
Charlotte,
North Carolina
|
-$2.09M |
| 3 |
GC
Globeflex Capital
San Diego,
California
|
-$1.82M |
| 4 |
PI
Putnam Investments
Boston,
Massachusetts
|
-$1.62M |
| 5 |
FQ
First Quadrant
Glendale,
California
|
-$1.16M |
BSTC Hedge Fund Activity: Q2 2017 in Review
90 of the 4,011 institutional investors tracked by Wall St. Rank reported a position in BioSpecifics Technologies Corp. (BSTC) for Q2 2017, worth a combined $199M — down 22% from $255M a quarter earlier.
Buyers outnumbered sellers: 7 funds opened new BSTC positions and 6 closed out — a net gain of 1 holder — while 34 added to existing stakes and 34 trimmed.
The largest buyer was Stonepine Capital Management, opening a new position worth an estimated $3.14M. The largest seller was Numeric Investors, cutting an estimated $2.74M.
- 90 institutional investors held BioSpecifics Technologies Corp. (BSTC) as of Q2 2017, up from 89 in Q1 2017.
- Funds reported $199M of BioSpecifics Technologies Corp. stock for Q2 2017, down 22% quarter-over-quarter.
- 7 funds opened new BioSpecifics Technologies Corp. positions in Q2 2017 and 6 closed out, a net change of +1 holder.
- The largest BioSpecifics Technologies Corp. buyer in Q2 2017 was Stonepine Capital Management, an estimated $3.14M added.
- The largest BioSpecifics Technologies Corp. seller in Q2 2017 was Numeric Investors, an estimated $2.74M sold.
Based on aggregated 13F filings for Q2 2017.